Inhibitory effect of a growth hormone receptor antagonist (G120K-PEG) on renal enlargement, glomerular hypertrophy, and urinary albumin excretion in experimental diabetes in mice
FLYVBJERG, A, BENNETT, W. F, RASCH, R, KOPCHICK, J. J, SCARLETT, J. A
Published in Diabetes (New York, N.Y.) (01.02.1999)
Published in Diabetes (New York, N.Y.) (01.02.1999)
Get full text
Journal Article
Modulation of growth hormone signal transduction in kidneys of streptozotocin-induced diabetic animals: Effect of a growth hormone receptor antagonist
THIRONE, Ana C. P, SCARLETT, John A, GASPARETTI, Alessandra L, ARAUJO, Eliana P, LIMA, Maria H. L, CARVALHO, Carla R. O, VELLOSO, Licio A, SAAD, Mario J. A
Published in Diabetes (New York, N.Y.) (01.07.2002)
Published in Diabetes (New York, N.Y.) (01.07.2002)
Get full text
Journal Article
Control of Tumor Size and Disease Activity during Cotreatment with Octreotide and the Growth Hormone Receptor Antagonist Pegvisomant in an Acromegalic Patient
van der Lely, Aart Jan, Muller, Alex F, Janssen, Joop A, Davis, Robert J, Zib, Kenneth A, Scarlett, John A, Lamberts, Steven W
Published in The journal of clinical endocrinology and metabolism (01.02.2001)
Published in The journal of clinical endocrinology and metabolism (01.02.2001)
Get full text
Journal Article
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
van der Lely, Aart Jan, Hutson, R Kent, Trainer, Peter J, Besser, G Michael, Barkan, Ariel L, Katznelson, Laurence, Klibanski, Anne, Herman-Bonert, Vivien, Melmed, Shlomo, Vance, Mary Lee, Freda, Pamela U, Stewart, Paul M, Friend, Keith E, Clemmons, David R, Johannsson, Gudmundur, Stavrou, Stavros, Cook, David M, Phillips, Lawrence S, Strasburger, Christian J, Hacker, Suzanne, Zib, Kenneth A, Davis, Robert J, Scarlett, John A, Thorner, Michael O
Published in The Lancet (British edition) (24.11.2001)
Published in The Lancet (British edition) (24.11.2001)
Get full text
Journal Article
Modulation of Growth Hormone Signal Transduction in Kidneys of Streptozotocin-Induced Diabetic Animals
Thirone, Ana C.P., Scarlett, John A., Gasparetti, Alessandra L., Araujo, Eliana P., Lima, Maria H.L., Carvalho, Carla R.O., Velloso, Lício A., Saad, Mario J.A.
Published in Diabetes (New York, N.Y.) (01.07.2002)
Published in Diabetes (New York, N.Y.) (01.07.2002)
Get full text
Journal Article
Fludarabine based combinations are highly effective as first-line or salvage treatment in patients with Waldenström macroglobulinemia
Peinert, Stefan, Tam, Constantine S., Prince, H. Miles, Scarlett, John, Wolf, Max M., Januszewicz, E. Henry, Westerman, David, Seymour, John F.
Published in Leukemia & lymphoma (01.12.2010)
Published in Leukemia & lymphoma (01.12.2010)
Get full text
Journal Article
Fludarabine Based Combinations Are Highly Effective as First-Line or Salvage Treatment in Patients with Waldenström Macroglobulinemia
Peinert, Stefan, Tam, Constantine, Prince, H. Miles, Wolf, Max M., Januszewicz, E. Henry, Westerman, David, Scarlett, John D., Seymour, John F.
Published in Blood (16.11.2008)
Published in Blood (16.11.2008)
Get full text
Journal Article
Fludarabine Based Combinations Are Highly Effective as First-Line or Salvage Treatment in Patients with Waldenström Macroglobulinemia
Peinert, Stefan, Tam, Constantine, Prince, H. Miles, Wolf, Max M., Januszewicz, E. Henry, Westerman, David, Scarlett, John D., Seymour, John F.
Published in Blood (16.11.2008)
Published in Blood (16.11.2008)
Get full text
Journal Article
Control of tumor size and disease activity during cotreatment with octreotide and the growth hormone receptor antagonist pegvisomant in an acromegalic patient
VAN DER LELY, Aart Jan, MULLER, Alex F, JANSSEN, Joop A, DAVIS, Robert J, ZIB, Kenneth A, SCARLETT, John A, LAMBERTS, Steven W
Published in The journal of clinical endocrinology and metabolism (01.02.2001)
Published in The journal of clinical endocrinology and metabolism (01.02.2001)
Get full text
Journal Article
Growth hormone (gh) receptor blockade with a peg-modified GH (B2036-PEG) lowers serum insulin-like growth factor-I but does not acutely stimulate serum GH
THORNER, M. O, STRASBURGER, C. J, WU, Z, STRAUME, M, BIDLINGMAIER, M, PEZZOLI, S. S, ZIB, K, SCARLETT, J. C, BENNETT, W. F
Published in The journal of clinical endocrinology and metabolism (01.06.1999)
Published in The journal of clinical endocrinology and metabolism (01.06.1999)
Get full text
Journal Article
Factitious hypoglycemia. Diagnosis by measurement of serum C-peptide immunoreactivity and insulin-binding antibodies
Scarlett, J A, Mako, M E, Rubenstein, A H, Blix, P M, Goldman, J, Horwitz, D L, Tager, H, Jaspan, J B, Stjernholm, M R, Olefsky, J M
Published in The New England journal of medicine (10.11.1977)
Published in The New England journal of medicine (10.11.1977)
Get more information
Journal Article
Early and late infectious consequences of adding rituximab to fludarabine and cyclophosphamide in patients with indolent lymphoid malignancies
Tam, C, Seymour, JF, Brown, M, Campbell, P, Scarlett, J, Underhill, C, Ritchie, D, Bond, R, Grigg, AP
Published in Haematologica (Roma) (01.05.2005)
Get full text
Published in Haematologica (Roma) (01.05.2005)
Journal Article
A Comparison of Acute and Delayed Infection Rates among Patients with Indolent Lymphoid Malignancies Receiving Fludarabine(F) and Cyclophosphamide(C) with or without Rituximab(R)
Tam, Constantine S., Seymour, John Francis, Brown, Michael, Campbell, Philip, Scarlett, John D., Underhill, Craig, Ritchie, David, Bond, Rodney, Grigg, Andrew
Published in Blood (16.11.2004)
Published in Blood (16.11.2004)
Get full text
Journal Article